Krishna Ella
Indian biotech scientist
Krishna Ella ▸ Facts ▸ Comments ▸ News ▸ Videos
Krishna Ella is an Indian scientist and entrepreneur. He is the founder and chairman of Bharat Biotech where he is also a Managing Director. Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin.
| 0 shares | ShareTweetSavePostSend |
You Might Like
First Indian intranasal Covid vaccine to be launched on January 26Homegrown vaccine maker Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella..IndiaTimes - Published | |
Bharat Biotech expects regulator's nod for intranasal Covid-19 vaccine in AugustBharat Biotech, which is working on an intranasal Covid-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, chairman and managing director of the company,..IndiaTimes - Published | |
Bharat Biotech's Covid nasal vaccine phase 3 trials completedThe company will submit its data to the Drugs Controller General of India (DCGI) next month, said Dr Krishna Ella, Bharat Biotech chief.DNA - Published | |
Lost 10 years of life in 18 months due to Covaxin stress, says Krishna EllaIn a face-to-face interview, Ella opened up to TOI about the thrill of developing India’s first indigenous Covid-19 vaccine, but also spoke about the dangers and controversies that dogged the company..IndiaTimes - Published | |
When should you take booster shot of COVID-19 vaccine? Bharat Biotech Chairman says THISBharat Biotech is also looking at nasal vaccine as a booster dose, Chairman and Managing Director Krishna Ella said.DNA - Published | |
Covid: Booster dose of vaccine required if virus gets mutated, says Bharat Biotech ChairmanPeople will need booster doses of the Covid-19 vaccine if the virus gets mutated, said chairman and MD of Bharat Biotech, Dr Krishna Ella. "If there is a mutated Covid-19 virus then a booster is..IndiaTimes - Published | |
Amid looming fear of COVID-19 third wave, Bharat Biotech CMD makes BIG statement over booster doseDr Krishna Ella stated that the nasal vaccine is more effective in preventing infection in the lungs as compared to the injected vaccineDNA - Published | |
We are waiting for DCGI approval for children's Covid-19 vaccine: Bharat Bitoech ChairmanChairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the Covid-19 vaccine for..IndiaTimes - Published | |
Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairmanCovaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr Krishna Ella said on Tuesday. Pointing..IndiaTimes - Published | |
First commercial batch of Covaxin rolls out from Bharat Biotech's Ankleshwar plantIn a move that will augment the supply of indigenously developed Covid-19 vaccine Covaxin, Bharat Biotech on Sunday announced the rollout of the first commercial batch of Covaxin from its Chiron..IndiaTimes - Published | |
